Collegium Pharmaceutical Q3 EPS $0.05 Beats $(0.15) Estimate, Sales $72.942M Miss $74.46M Estimate

Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.15) by 133.33 percent. This is a 120 percent increase over losses of $(0.25) per

Benzinga · 11/06/2019 21:37

Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.15) by 133.33 percent. This is a 120 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $72.942 million which missed the analyst consensus estimate of $74.46 million by 2.04 percent. This is a 3.94 percent increase over sales of $70.176 million the same period last year.